James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

Microsoft Corporation (MSFT) Is Building an AI Monster

Microsoft (MSFT) hasn't defined itself as an artificial intelligence powerhouse, but that doesn't mean it isn't one.

Why Rite Aid Corporation (RAD), Qualcomm, Inc. (QCOM) and Halliburton Company (HAL) Are 3 of Today’s Worst Stocks

Qualcomm (QCOM), Halliburton (HAL) and Rite Aid (RAD) used more than their fair share of red ink on the first trading day of the week.

Whole Foods Market, Inc. (WFM) Won’t Survive Unless …

Whole Foods gets a lot of the credit for creating the organic and natural food market, but the market has changed considerably. Now, WFM needs to adapt.

Nokia Corp (ADR) (NOK) Stock’s New Smartphone Lineup Won’t Help It

If you're looking at Nokia stock because it's getting back in the smartphone business, look elsewhere. NOK stock isn't worth it.

Why Rite Aid Corporation (RAD), General Electric Company (GE) and Bristol-Myers Squibb Co (BMY) Are 3 of Today’s Worst Stocks

Rite Aid (RAD), Bristol-Myers Squibb (BMY) and General Electric (GE) ended the trading week on a bearish foot.